MTD:NYE-Mettler-Toledo International Inc. (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 1162.84

Change

+48.70 (+4.37)%

Market Cap

USD 10.87B

Volume

0.16M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Mettler-Toledo International Inc is engaged in the supply of precision instruments and services. It is a provider of weighing instruments for use in laboratory, industrial and food retailing applications.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-27 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

+1.46 (+0.77%)

USD 140.35B
A Agilent Technologies Inc

+2.40 (+2.16%)

USD 32.44B
IQV IQVIA Holdings Inc

+2.24 (+1.61%)

USD 24.71B
LH Laboratory Corporation of Amer..

-0.28 (-0.11%)

USD 20.88B
DGX Quest Diagnostics Incorporated

+0.62 (+0.36%)

USD 19.12B
QGEN Qiagen NV

+0.62 (+1.40%)

USD 9.05B
CRL Charles River Laboratories

+1.45 (+1.06%)

USD 6.92B
ENZ Enzo Biochem Inc

+0.01 (+0.85%)

USD 0.02B
TMO Thermo Fisher Scientific Inc

+1.62 (+0.40%)

N/A
WAT Waters Corporation

+0.71 (+0.20%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

+0.10 (+0%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

+0.02 (+0%)

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

N/A

N/A
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

-0.32 (0%)

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+2.33 (+0%)

USD 5.43B
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.97% 67% D+ 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.97% 67% D+ 28% F
Trailing 12 Months  
Capital Gain -20.05% 58% F 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -20.05% 58% F 13% F
Trailing 5 Years  
Capital Gain 46.75% 73% C 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 46.75% 73% C 47% F
Average Annual (5 Year Horizon)  
Capital Gain 7.82% 83% B 65% D
Dividend Return 7.82% 83% B 58% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 24.84% 67% D+ 39% F
Risk Adjusted Return 31.47% 83% B 49% F
Market Capitalization 10.87B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike